Authors:
SKELLY JP
VANBUSKIRK GA
ARBIT HM
AMIDON GL
AUGSBURGER L
BARR WH
BERGE S
CLEVENGER J
DIGHE S
FOX D
GONZALEZ MA
GRAY VA
HOIBERG C
JERUSSI R
LEESON LJ
LESKO L
MALINOWSKI H
NIXON PR
PEARCE DM
PECK G
PORTER S
ROBINSON J
SAVELLO DR
SCHWARTZ P
SCHWARTZ JB
SHAH VP
THEEUWES F
WHEATLEY T
Citation: Jp. Skelly et al., WORKSHOP-II REPORT - SCALE-UP OF ORAL EXTENDED-RELEASE DOSAGE FORMS, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 162-167
Authors:
SKELLY JP
VANBUSKIRK GA
ARBIT HM
AMIDON GL
AUGSBURGER L
BARR WH
BERGE S
CLEVENGER J
DIGHE S
FAWZI M
FOX D
GONZALEZ MA
GRAY VA
HOIBERG C
LEESON LJ
LESKO L
MALINOWSKI H
NIXON PR
PEARCE DM
PECK G
PORTER S
ROBINSON J
SAVELLO DR
SCHWARTZ P
SCHWARTZ JB
SHAH VP
SHANGRAW R
THEEUWES F
WHEATLEY T
Citation: Jp. Skelly et al., SCALEUP OF ORAL EXTENDED-RELEASE DOSAGE FORMS, Pharmaceutical research, 10(12), 1993, pp. 1800-1807
Authors:
MCMAHON FG
VARGAS R
LEESE P
CRAWFORD B
KONECNY A
NICHOLS K
KNOWLES M
THEEUWES F
GUINTA D
Citation: Fg. Mcmahon et al., CONTROLLED-RELEASE DOSAGE FORMS AND GASTROINTESTINAL BLOOD-LOSS - 4 CLINICAL-STUDIES, International journal of pharmaceutics, 91(1), 1993, pp. 75-84